Prostaglandin-J2 induces synthesis of interleukin-8 by endothelial cells in a PPARγ-independent manner

Prostaglandins and Other Lipid Mediators

Volumn 66, Issue 3, 2001, Pages 165-177

  Jozkowicz, Alicja ^a,b   Dulak, Jozef ^c   Prager, Manfred ^a   Nanobashvili, Josef ^a   Nigisch, Anneliese ^a   Winter, Birgitta ^a   Weigel, Guenter ^a   Huk, Ihor ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^c UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXY DELTA 12,14 PROSTAGLANDIN J2; CIGLITAZONE; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; LUCIFERASE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN J2; UNCLASSIFIED DRUG; 2,4 THIAZOLIDINEDIONE DERIVATIVE; 9-DEOXY-DELTA-9-PROSTAGLANDIN D2; CELL RECEPTOR; DRUG DERIVATIVE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIGAND; PROSTAGLANDIN D2; THIAZOLE DERIVATIVE; TRANSCRIPTION FACTOR;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG POTENCY; ENDOTHELIUM CELL; ENZYME ASSAY; HUMAN; HUMAN CELL; INFLAMMATION; MEDIATOR; PROTEIN EXPRESSION; PROTEIN INDUCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEADY STATE; BIOSYNTHESIS; CELL LINE; CELL SURVIVAL; DRUG EFFECT; GEL MOBILITY SHIFT ASSAY; GENETIC TRANSFECTION; GENETICS; METABOLISM; UPREGULATION; VASCULAR ENDOTHELIUM;

CELL LINE; CELL SURVIVAL; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENDOTHELIUM, VASCULAR; HUMANS; INTERLEUKIN-8; LIGANDS; NF-KAPPA B; PROSTAGLANDIN D2; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THIAZOLES; THIAZOLIDINEDIONES; TRANSCRIPTION FACTORS; TRANSFECTION; UP-REGULATION;

EID: 0034741358     PISSN: 00906980     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-6980(01)00155-1     Document Type: Article

References (38)

1. PPARs: A nuclear receptor signaling pathway in lipid metabolism
2. Peroxisome proliferator-activated receptors: Three isotypes for a multitude of functions
3. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor-γ (PPARγ)
4. 2 metabolite binds peroxisome proiferator-activated receptor, and promotes adipocyte differentiation
5. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
6. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
7. Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells
8. Peroxisome proliferator-activated receptor-γ ligands are potent inhibitors of angiogenesis in vitro and in vivo
9. Peroxisome proliferator activated receptor-γ ligands inhibit choroidal neovascularization
10. 2 induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats
11. The microcirculation during endotoxemia
12. Chemokines, leukocyte trafficking, and inflammation
13. Role of NFκB-mediated IL-8 expression in intravascular neovascularization
14. IL-8, and its receptor CXCR2 in atherosclerosis
15. IL-8 is an angiogenic factor in human coronary atheroctomy tissue
16. Another potential use of troglitazone in non-insulin dependent diabetes mellitus
17. Single step method of RNA isolation by guanidinum thiocyanate-phenol-chlorophorm extraction
18. Ligands of peroxisome proliferator-activated receptor-γ increase the generation of vascular endothelial growth factor in vascular smooth muscle cells and in macrophages
19. Differential activation of peroxisome proliferator-activated receptors by eicosanoids
20. A novel therapy for colitis utilizing PPARγ ligands to inhibit epithelial inflammatory response
21. 2 inhibits multiple steps in the NFκB signaling pathway
22. 2
23. Activation of peroxisome proliferator-activated receptor-γ does not inhibit IL-6 or TNFα responses of macrophages to lipopolysaccharide in vitro and in vivo
24. 2 inhibits the β-2 integrin-dependent oxidative burst: Involvement of a mechanism distinct from peroxisome proliferator activated receptor γ ligation
25. PPARγ-ligands inhibit migration mediated by multiple chemoattractants in vascular smooth muscle cells
26. 2
27. PPARγ dependent, and independent effects on macrophage-gene expression in lipid metabolism, and inflammation
28. Activation of PPARα or γ reduces secretion of matrix metalloproteinese 9 but not intereukin 8 from human endothelial monocytic THP-1 cells
29. Role for peroxisome proliferator-activated reeceptor alpha in oxidized phospholipid-induced synthesis of monocyte chemotactic protein-1 and IL-8 by endothelial cells
30. Troglitazone, an antidiabetic agent, inhibits cholesterol biosynthesis through a mechanism independent of peroxisome proliferator-activated receptor-γ
31. 2 stimulates IL-8 gene expression in human colonic epithelial cells by a posttranscriptional mechanism
32. Rapid secretion of prestored IL-8 from Weibel-Palade bodies of microvascular endothelial cells
33. Cooperation between transcription factor AP-1 and NFκB in the induction of IL-8 in human pancreatic adenocarcinoma cells by hypoxia
34. 2: A biochemical perspective
35. Macrophages in human atheroma contain PPARγ. Differentiation-dependent PPARγ expression and reduction of MMP-9 activity through PPARγ activation in mononuclear phagocytes
36. Expression of the peroxisome activated receptor gamma (PPARγ) in human atherosclerosis and regulation in macrophages by colony stimulating factor and oxidized low density lipoprotein
37. Ligands for peroxisome proliferator-activated receptor gamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice
38. Differentiation and reversal of malignant changes in colon cancer through PPARγ